In Silico Repositioning for Dual Inhibitor Discovery of SARS-CoV-2 (COVID-19) 3c-Like Protease and Papain-Like Peptidase

doi 10.20944/preprints202004.0084.v1

Full Text

Abstract

Available in

Date

April 7, 2020

Authors

Kowsar Bagherzadeh

Kourosh Daneshvarnejad

Mohammad Abbasinazari

Publisher

MDPI AG

Related search

Inhibitor Recognition Specificity of MERS-CoV Papain-Like Protease May Differ From That of SARS-CoV

English

In Silico Approach of Some Selected Honey Constituents as SARS-CoV-2 Main Protease (COVID-19) Inhibitors

English

Inhibition of SARS-CoV 3c-Like Protease Activity by Theaflavin-3,3'-Digallate (TF3)

Evidence-based Complementary and Alternative Medicine

Alternative Medicine

English

Scutellaria Baicalensis Extract and Baicalein Inhibit Replication of SARS-CoV-2 and Its 3c-Like Protease in Vitro

English

Characteristics of Flavonoids as Potent MERS ‐CoV 3C‐like Protease Inhibitors

Chemical Biology and Drug Design

Organic Chemistry

Molecular Medicine

English

Isatin Compounds as Noncovalent SARS Coronavirus 3c-Like Protease Inhibitors

English

Important Steps to Control COVID-19/SARS-CoV-2 Infection

SN Comprehensive Clinical Medicine

English

A SARS-CoV-2/COVID-19 Em Pacientes Com Câncer

Revista Brasileira de Cancerologia

Portuguese

Call for Papers: The Pathophysiology of COVID-19 and SARS-CoV-2 Infection

American Journal of Physiology - Lung Cellular and Molecular Physiology

Respiratory Medicine

English